Inovio Pharmaceuticals Inc. Stock Sheds 5.6%, Underperforms Peers
Dow Jones2026/10/08 20:34This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Inovio Pharmaceuticals Inc. slipped 5.6% to $1.09 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.1% to 51,231.64 and the NASDAQ Composite Index falling 1.3% to 27,193.34. Inovio Pharmaceuticals Inc. closed 59.9% short of its 52-week high of $2.72, which the company achieved on December 17th. The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.8% to $256.48, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.64% to $27.82. Trading volume totaled 3.0 million, compared to the 50-day average of 4.5 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 08, 2026 16:34 ET (20:34 GMT)
This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. slipped 5.6% to $1.09 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.1% to 51,231.64 and the NASDAQ Composite Index falling 1.3% to 27,193.34.
Inovio Pharmaceuticals Inc. closed 59.9% short of its 52-week high of $2.72, which the company achieved on December 17th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.8% to $256.48, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.64% to $27.82.
Trading volume totaled 3.0 million, compared to the 50-day average of 4.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 08, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.
Swiss Franc weakens as Fed hawkish outlook lifts USD/CHF
Crypto prices
More
